Piramal Pharma Limited — Spironolactone Exporter Profile
Indian Pharmaceutical Exporter · #7 for Spironolactone · $2.2M export value · DGFT Verified
Piramal Pharma Limited is the #7 Indian exporter of Spironolactone with $2.2M in export value and 44 verified shipments. Piramal Pharma Limited holds a 1.1% market share in Spironolactone exports across 2 countries. The company exports 8 pharmaceutical products worth $64.5M across 5 therapeutic categories.
Piramal Pharma Limited — Spironolactone Export Profile: Buyers & Destinations
Where Does Piramal Pharma Limited Export Spironolactone?
| Country | Value | Shipments | Share |
|---|---|---|---|
| UNITED KINGDOM | $1.0M | 27 | 63.8% |
| NETHERLANDS | $594.2K | 17 | 36.2% |
Piramal Pharma Limited exports Spironolactone to 2 countries. The largest destination is UNITED KINGDOM accounting for 63.8% of Piramal Pharma Limited's Spironolactone shipments. These destinations reflect Piramal Pharma Limited's established distribution network and regulatory approvals in key markets.
Who Are the Top Buyers of Spironolactone from Piramal Pharma Limited?
| Buyer | Country | Value | Orders |
|---|---|---|---|
| LEXON UK LIMITED | UNITED KINGDOM | $997.5K | 26 |
| BROCACEF HEALTHCARE LOGISTICS | NETHERLANDS | $310.9K | 9 |
| VTS TRANSPORT LOGISTICS BV | NETHERLANDS | $250.0K | 5 |
| LEXON UK LTD | UNITED KINGDOM | $50.0K | 1 |
| VTS TRANSPORT & LOGISTICS BV | NETHERLANDS | $33.4K | 3 |
Piramal Pharma Limited supplies Spironolactone to 5 buyers globally. The largest buyer is LEXON UK LIMITED (UNITED KINGDOM), followed by BROCACEF HEALTHCARE LOGISTICS (NETHERLANDS) and VTS TRANSPORT LOGISTICS BV (NETHERLANDS). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.
What Is India's Total Spironolactone Export Value and How Much Does Piramal Pharma Limited Contribute?
India exported $67.2M worth of Spironolactone through 5,262 shipments from 259 suppliers to 112 countries, serving 471 buyers globally. Piramal Pharma Limited contributes $2.2M to this total, accounting for 1.1% of India's Spironolactone exports. Piramal Pharma Limited ships Spironolactone to 2 countries through 5 buyers.
What Is the Average Shipment Value for Piramal Pharma Limited's Spironolactone Exports?
Piramal Pharma Limited's average Spironolactone shipment value is $50.0K per consignment, based on 44 shipments totaling $2.2M. The largest destination is UNITED KINGDOM (63.8% of Piramal Pharma Limited's Spironolactone exports).
How Does Piramal Pharma Limited Compare to Other Indian Spironolactone Exporters?
Piramal Pharma Limited ranks #7 among 259 Indian Spironolactone exporters with a 1.1% market share. The top 3 exporters are AMNEAL PHARMACEUTICALS PRIVATE LIMITED ($18.6M), ZYDUS LIFESCIENCES LIMITED ($13.1M), INTAS PHARMACEUTICALS LIMITED ($12.2M). Piramal Pharma Limited processed 44 shipments to 2 destination countries.
What Spironolactone Formulations Does Piramal Pharma Limited Export?
| Product Description / Formulation | Value | Shipments |
|---|---|---|
| Spironolactone 12.5mg Tab PVC BL 2x14sNL | $250.0K | 5 |
| SPIRONOLACTONE 12.5 MG TB PVC BL 2 X 14S | $100.0K | 2 |
| Spironolactone 100mg Tabs PVC BL 2x14s ( | $100.0K | 2 |
| Spironolactone 50mg Tabs PVC BL 2x14s (4 | $100.0K | 2 |
| SPIRONOLACTONE 12.5MG TAB VC BL2X14S UK(400691057) (95,466.000 SB ) | $64.0K | 3 |
| SPIRONOLACTONE 12.5MG TAB PVC BL2X14S UK(400691057) (71,629.000 SB ) | $53.0K | 3 |
| SPIRONOLACTONE 25MG TABS PVC BL 2 X 14S | $50.0K | 1 |
| SPIRONOLACTONE 12.5MG TB PVC BL 2X14SNLD | $50.0K | 1 |
| Spironolactone 12.5mg Tabs PVC BL 2x14s | $50.0K | 1 |
| Spironolactone 12 5mg Tabs PVC BL 2x14s 400691038 89987 00 SB | $50.0K | 1 |
Piramal Pharma Limited exports 29 distinct Spironolactone formulations including tablets, capsules, syrups, and combination drugs. The top formulation is Spironolactone 12.5mg Tab PVC BL 2x14sNL with 5 shipments worth $250.0K.
Regulatory Requirements: Exporting Spironolactone to Key Markets
What Piramal Pharma Limited must comply with to export Spironolactone to its top destination countries
United Kingdom — MHRA
Approval Process
Post-Brexit UK Marketing Authorisation via national procedure. Separate from EU approval since January 2021.
Timeline: 12–15 months
GMP & Export Requirements
UK GMP compliance; MHRA inspection of manufacturing site
Manufacturer Import Authorisation (MIA) held by UK importer; Qualified Person (QP) batch release
Note: Post-Brexit: EU GMP certificates no longer automatically valid in UK. Separate MHRA recognition required.
Regulatory information is provided for general reference based on publicly available guidelines. Requirements vary by formulation, dosage form, and therapeutic classification. Exporters should consult qualified regulatory affairs professionals for case-specific guidance.
How Does Piramal Pharma Limited Compare to Nearest Spironolactone Exporters?
Exporters ranked immediately above and below #7 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 5 | AUROBINDO PHARMA LIMITED | $5.0M | 101 | 1 | $50.0K |
| 6 | CADILA HEALTHCARE LIMITED | $2.5M | 49 | 1 | $50.0K |
| 7 | PIRAMAL PHARMA LIMITED ★ | $2.2M | 44 | 2 | $50.0K |
| 8 | COHANCE LIFESCIENCES LIMITED | $1.6M | 32 | 2 | $50.0K |
| 11 | STERIL-GENE LIFE SCIENCES PRIVATE LIMITED | $730.6K | 32 | 1 | $22.8K |
Piramal Pharma Limited ranks #7 among 259 Indian Spironolactone exporters. Average shipment value of $50.0K compared to the market average of $259.6K. The closest competitors by value are AUROBINDO PHARMA LIMITED and CADILA HEALTHCARE LIMITED.
Which Indian Ports Ship Spironolactone Exports?
| Port | Shipments | % Share |
|---|---|---|
| DELHI AIR CARGO ACC (INDEL4) | 870 | 16.5% |
| DELHI AIR | 678 | 12.9% |
| SAHAR AIR | 633 | 12.0% |
| SAHAR AIR CARGO ACC (INBOM4) | 594 | 11.3% |
| MUNDRA SEA | 443 | 8.4% |
| MUNDRA SEA (INMUN1) | 391 | 7.4% |
| Delhi Air | 164 | 3.1% |
| NHAVA SHEVA SEA (INNSA1) | 132 | 2.5% |
Geopolitical & Trade Policy Impact on Piramal Pharma Limited's Spironolactone Exports
The current geopolitical landscape presents both challenges and opportunities for Indian pharmaceutical exporters like PPL. The Israel-Iran tensions have led to increased security risks in the Red Sea, prompting major shipping lines to impose 'Emergency Risk Surcharges' ranging from $250 to $500 per TEU. This escalation in shipping costs directly impacts the profitability of exports to Europe and the U.S. East Coast, necessitating strategic adjustments in logistics and pricing strategies. (sgexports.odoo.com)
Simultaneously, the 2025 United States–India diplomatic and trade crisis has introduced additional complexities. The U.S. administration's imposition of a 50% tariff on Indian exports, in response to India's energy policies, has significantly affected trade dynamics. This development compels companies like PPL to reassess their market strategies and explore alternative markets to mitigate the impact of these tariffs. (en.wikipedia.org)
On a positive note, the European Union's implementation of the Carbon Border Adjustment Mechanism (CBAM) has prompted the Directorate General of Foreign Trade (DGFT) in India to establish a 'CBAM Facilitation Cell.' This initiative aims to assist exporters in complying with new environmental regulations, potentially providing PPL with a competitive edge in the EU market by aligning with sustainability standards. (sgexports.odoo.com)
Piramal Pharma Limited — Regulatory Compliance & Quality Standards
Maintaining stringent quality standards is paramount for pharmaceutical exporters. PPL's Turbhe facility in Maharashtra underwent a U.S. FDA inspection in February 2025, resulting in a Form 483 with six observations. The company addressed these concerns, leading to the issuance of an Establishment Inspection Report (EIR) with a classification of Voluntary Action Indicated (VAI) in May 2025, signifying successful closure of the inspection. (business-standard.com)
Similarly, the Riverview facility in the U.S. received an EIR in April 2024, following a pre-approval inspection that concluded with three observations classified under VAI. These developments reflect PPL's proactive approach to regulatory compliance and its commitment to upholding global quality standards. (business-standard.com)
About Piramal Pharma Limited
Piramal Pharma Limited exports 8 products worth $64.5M. Beyond Spironolactone, top products include Atorvastatin, Calcium, Ezetimibe, Carvedilol, Iron. View the complete Piramal Pharma Limited profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Spironolactone — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Spironolactone shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
- 2.Supplier Identification: Piramal Pharma Limited matched across shipments using name normalization, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
- 4.Verified Records: This page is backed by 44 individual customs records matching Piramal Pharma Limited exporting Spironolactone, covering 29 formulations to 2 countries via 5 buyers.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 112+ countries, 471+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Spironolactone Export Data from Piramal Pharma Limited
Access shipment-level details, pricing data, buyer connections, and competitive analysis for Piramal Pharma Limited's Spironolactone exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
Piramal Pharma Limited
Full Company Profile →
8 products · $64.5M total trade · 5 categories
Spironolactone Stats
Company Overview
Top Products by Piramal Pharma Limited
Related Analysis
Need Detailed Export Data?
Access shipment-level records, pricing trends, and buyer contacts for Piramal Pharma Limited.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Spironolactone. For current shipment-level data, contact TransData Nexus.